Trials / Completed
CompletedNCT00946530
Light Treatment for Sleep/Wake Disturbances in Alzheimer's Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 118 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 55 Years – 100 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to demonstrate the efficacy of timed exposure to bright light for the treatment of disturbed nighttime sleep and daytime wake in community-dwelling dementia patients and their caregivers, and to determine if there are genetic relationships between memory problems and sleep problems
Detailed description
1. Efficacy: Up to 4 weeks of morning bright light exposure will be more efficacious than morning dim light in consolidating nighttime sleep as assessed by actigraphy. 2. Predictors of response: We expect the primary predictor of treatment response will be initial MMSE score. Secondary predictors include baseline sleep/wake and circadian parameters and age. 3. Effectiveness: Bright light treatment will be more effective than dim light in improving quality of life. 4. An understanding of some of the genetic markers of memory and/or sleep problems.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Bright light | Participants uses bright light |
| DEVICE | Control | Participants uses dim light |
Timeline
- Start date
- 2004-09-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2009-07-27
- Last updated
- 2018-10-03
- Results posted
- 2017-03-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00946530. Inclusion in this directory is not an endorsement.